Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 4 |
NetGPI | no | yes: 0, no: 4 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000932 | P-body | 5 | 2 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005737 | cytoplasm | 2 | 2 |
GO:0030015 | CCR4-NOT core complex | 3 | 5 |
GO:0032991 | protein-containing complex | 1 | 5 |
GO:0035770 | ribonucleoprotein granule | 3 | 2 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 4 | 2 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043228 | non-membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 2 |
GO:0099080 | supramolecular complex | 2 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0140535 | intracellular protein-containing complex | 2 | 5 |
Related structures:
AlphaFold database: Q4QGQ8
Term | Name | Level | Count |
---|---|---|---|
GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening | 8 | 2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 7 | 2 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 2 |
GO:0006355 | regulation of DNA-templated transcription | 6 | 5 |
GO:0006401 | RNA catabolic process | 5 | 2 |
GO:0006402 | mRNA catabolic process | 6 | 2 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 2 |
GO:0006807 | nitrogen compound metabolic process | 2 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009056 | catabolic process | 2 | 2 |
GO:0009057 | macromolecule catabolic process | 4 | 2 |
GO:0009889 | regulation of biosynthetic process | 4 | 5 |
GO:0009892 | negative regulation of metabolic process | 4 | 2 |
GO:0009987 | cellular process | 1 | 2 |
GO:0010468 | regulation of gene expression | 5 | 5 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 5 |
GO:0010605 | negative regulation of macromolecule metabolic process | 5 | 2 |
GO:0010629 | negative regulation of gene expression | 6 | 2 |
GO:0016070 | RNA metabolic process | 5 | 2 |
GO:0016071 | mRNA metabolic process | 6 | 2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 5 |
GO:0019222 | regulation of metabolic process | 3 | 5 |
GO:0019439 | aromatic compound catabolic process | 4 | 2 |
GO:0031323 | regulation of cellular metabolic process | 4 | 5 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 5 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 2 |
GO:0034655 | nucleobase-containing compound catabolic process | 4 | 2 |
GO:0043170 | macromolecule metabolic process | 3 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0044238 | primary metabolic process | 2 | 2 |
GO:0044248 | cellular catabolic process | 3 | 2 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 2 |
GO:0044265 | obsolete cellular macromolecule catabolic process | 4 | 2 |
GO:0044270 | cellular nitrogen compound catabolic process | 4 | 2 |
GO:0046483 | heterocycle metabolic process | 3 | 2 |
GO:0046700 | heterocycle catabolic process | 4 | 2 |
GO:0048519 | negative regulation of biological process | 3 | 2 |
GO:0050789 | regulation of biological process | 2 | 5 |
GO:0050794 | regulation of cellular process | 3 | 5 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 5 |
GO:0051252 | regulation of RNA metabolic process | 5 | 5 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 5 |
GO:0065007 | biological regulation | 1 | 5 |
GO:0071704 | organic substance metabolic process | 2 | 2 |
GO:0080090 | regulation of primary metabolic process | 4 | 5 |
GO:0090304 | nucleic acid metabolic process | 4 | 2 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 2 |
GO:1901361 | organic cyclic compound catabolic process | 4 | 2 |
GO:1901575 | organic substance catabolic process | 3 | 2 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 5 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 5 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 338 | 342 | PF00656 | 0.698 |
CLV_NRD_NRD_1 | 67 | 69 | PF00675 | 0.754 |
CLV_PCSK_KEX2_1 | 67 | 69 | PF00082 | 0.754 |
CLV_PCSK_SKI1_1 | 425 | 429 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 473 | 477 | PF00082 | 0.432 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.754 |
DEG_COP1_1 | 318 | 325 | PF00400 | 0.797 |
DOC_MAPK_gen_1 | 124 | 132 | PF00069 | 0.770 |
DOC_MAPK_JIP1_4 | 399 | 405 | PF00069 | 0.632 |
DOC_MAPK_MEF2A_6 | 308 | 316 | PF00069 | 0.777 |
DOC_PP2B_LxvP_1 | 130 | 133 | PF13499 | 0.777 |
DOC_PP2B_LxvP_1 | 49 | 52 | PF13499 | 0.750 |
DOC_PP4_FxxP_1 | 25 | 28 | PF00568 | 0.839 |
DOC_PP4_FxxP_1 | 389 | 392 | PF00568 | 0.524 |
DOC_PP4_MxPP_1 | 12 | 15 | PF00568 | 0.660 |
DOC_USP7_MATH_1 | 264 | 268 | PF00917 | 0.753 |
DOC_USP7_MATH_1 | 377 | 381 | PF00917 | 0.710 |
DOC_USP7_MATH_1 | 542 | 546 | PF00917 | 0.851 |
DOC_USP7_MATH_1 | 558 | 562 | PF00917 | 0.585 |
DOC_USP7_UBL2_3 | 304 | 308 | PF12436 | 0.731 |
DOC_USP7_UBL2_3 | 397 | 401 | PF12436 | 0.632 |
DOC_WW_Pin1_4 | 239 | 244 | PF00397 | 0.822 |
DOC_WW_Pin1_4 | 316 | 321 | PF00397 | 0.808 |
DOC_WW_Pin1_4 | 554 | 559 | PF00397 | 0.851 |
LIG_14-3-3_CanoR_1 | 105 | 113 | PF00244 | 0.747 |
LIG_14-3-3_CanoR_1 | 399 | 404 | PF00244 | 0.632 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.868 |
LIG_eIF4E_1 | 301 | 307 | PF01652 | 0.720 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.803 |
LIG_FHA_1 | 327 | 333 | PF00498 | 0.570 |
LIG_FHA_1 | 349 | 355 | PF00498 | 0.668 |
LIG_FHA_1 | 373 | 379 | PF00498 | 0.705 |
LIG_FHA_1 | 476 | 482 | PF00498 | 0.632 |
LIG_FHA_2 | 59 | 65 | PF00498 | 0.727 |
LIG_LIR_Apic_2 | 23 | 28 | PF02991 | 0.847 |
LIG_LIR_Apic_2 | 382 | 387 | PF02991 | 0.700 |
LIG_LIR_Apic_2 | 388 | 392 | PF02991 | 0.427 |
LIG_LIR_Apic_2 | 393 | 398 | PF02991 | 0.504 |
LIG_LIR_Gen_1 | 344 | 354 | PF02991 | 0.674 |
LIG_LIR_Gen_1 | 407 | 416 | PF02991 | 0.632 |
LIG_LIR_Gen_1 | 476 | 484 | PF02991 | 0.632 |
LIG_LIR_Nem_3 | 344 | 350 | PF02991 | 0.678 |
LIG_LIR_Nem_3 | 379 | 384 | PF02991 | 0.719 |
LIG_LIR_Nem_3 | 407 | 411 | PF02991 | 0.632 |
LIG_LIR_Nem_3 | 414 | 420 | PF02991 | 0.550 |
LIG_LIR_Nem_3 | 476 | 482 | PF02991 | 0.526 |
LIG_LIR_Nem_3 | 486 | 490 | PF02991 | 0.504 |
LIG_PCNA_yPIPBox_3 | 194 | 205 | PF02747 | 0.744 |
LIG_SH2_CRK | 395 | 399 | PF00017 | 0.632 |
LIG_SH2_CRK | 421 | 425 | PF00017 | 0.632 |
LIG_SH2_PTP2 | 384 | 387 | PF00017 | 0.688 |
LIG_SH2_SRC | 321 | 324 | PF00017 | 0.790 |
LIG_SH2_STAP1 | 381 | 385 | PF00017 | 0.622 |
LIG_SH2_STAT3 | 173 | 176 | PF00017 | 0.735 |
LIG_SH2_STAT5 | 321 | 324 | PF00017 | 0.752 |
LIG_SH2_STAT5 | 384 | 387 | PF00017 | 0.628 |
LIG_SH2_STAT5 | 418 | 421 | PF00017 | 0.637 |
LIG_SH2_STAT5 | 479 | 482 | PF00017 | 0.632 |
LIG_SH3_3 | 265 | 271 | PF00018 | 0.831 |
LIG_SH3_3 | 306 | 312 | PF00018 | 0.639 |
LIG_SH3_3 | 317 | 323 | PF00018 | 0.593 |
LIG_SH3_3 | 325 | 331 | PF00018 | 0.429 |
LIG_SH3_3 | 478 | 484 | PF00018 | 0.632 |
LIG_SH3_3 | 8 | 14 | PF00018 | 0.662 |
LIG_SH3_4 | 397 | 404 | PF00018 | 0.632 |
LIG_SUMO_SIM_anti_2 | 110 | 115 | PF11976 | 0.728 |
LIG_TRAF2_1 | 512 | 515 | PF00917 | 0.718 |
LIG_WRC_WIRS_1 | 405 | 410 | PF05994 | 0.632 |
LIG_WW_2 | 312 | 315 | PF00397 | 0.783 |
MOD_CK1_1 | 404 | 410 | PF00069 | 0.632 |
MOD_CK2_1 | 104 | 110 | PF00069 | 0.761 |
MOD_CK2_1 | 321 | 327 | PF00069 | 0.785 |
MOD_CK2_1 | 359 | 365 | PF00069 | 0.691 |
MOD_CK2_1 | 457 | 463 | PF00069 | 0.632 |
MOD_CK2_1 | 58 | 64 | PF00069 | 0.725 |
MOD_GlcNHglycan | 106 | 109 | PF01048 | 0.750 |
MOD_GlcNHglycan | 227 | 230 | PF01048 | 0.802 |
MOD_GlcNHglycan | 248 | 251 | PF01048 | 0.718 |
MOD_GlcNHglycan | 258 | 261 | PF01048 | 0.726 |
MOD_GlcNHglycan | 323 | 326 | PF01048 | 0.709 |
MOD_GlcNHglycan | 332 | 335 | PF01048 | 0.617 |
MOD_GlcNHglycan | 504 | 509 | PF01048 | 0.680 |
MOD_GlcNHglycan | 537 | 540 | PF01048 | 0.823 |
MOD_GlcNHglycan | 551 | 554 | PF01048 | 0.626 |
MOD_GlcNHglycan | 558 | 561 | PF01048 | 0.649 |
MOD_GSK3_1 | 175 | 182 | PF00069 | 0.734 |
MOD_GSK3_1 | 248 | 255 | PF00069 | 0.648 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.754 |
MOD_GSK3_1 | 368 | 375 | PF00069 | 0.699 |
MOD_GSK3_1 | 473 | 480 | PF00069 | 0.637 |
MOD_GSK3_1 | 554 | 561 | PF00069 | 0.799 |
MOD_N-GLC_1 | 146 | 151 | PF02516 | 0.758 |
MOD_N-GLC_1 | 156 | 161 | PF02516 | 0.554 |
MOD_N-GLC_1 | 256 | 261 | PF02516 | 0.839 |
MOD_N-GLC_1 | 345 | 350 | PF02516 | 0.675 |
MOD_N-GLC_1 | 548 | 553 | PF02516 | 0.688 |
MOD_N-GLC_1 | 554 | 559 | PF02516 | 0.710 |
MOD_N-GLC_2 | 444 | 446 | PF02516 | 0.289 |
MOD_NEK2_1 | 224 | 229 | PF00069 | 0.809 |
MOD_NEK2_1 | 345 | 350 | PF00069 | 0.675 |
MOD_NEK2_1 | 369 | 374 | PF00069 | 0.693 |
MOD_NEK2_1 | 462 | 467 | PF00069 | 0.545 |
MOD_NEK2_1 | 475 | 480 | PF00069 | 0.504 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.723 |
MOD_NEK2_2 | 477 | 482 | PF00069 | 0.632 |
MOD_PIKK_1 | 175 | 181 | PF00454 | 0.734 |
MOD_PIKK_1 | 189 | 195 | PF00454 | 0.519 |
MOD_PIKK_1 | 28 | 34 | PF00454 | 0.750 |
MOD_PIKK_1 | 335 | 341 | PF00454 | 0.723 |
MOD_PIKK_1 | 354 | 360 | PF00454 | 0.372 |
MOD_PIKK_1 | 489 | 495 | PF00454 | 0.632 |
MOD_PIKK_1 | 518 | 524 | PF00454 | 0.621 |
MOD_PKA_2 | 104 | 110 | PF00069 | 0.761 |
MOD_Plk_1 | 156 | 162 | PF00069 | 0.723 |
MOD_Plk_1 | 256 | 262 | PF00069 | 0.834 |
MOD_Plk_1 | 345 | 351 | PF00069 | 0.673 |
MOD_Plk_1 | 354 | 360 | PF00069 | 0.535 |
MOD_Plk_1 | 412 | 418 | PF00069 | 0.632 |
MOD_Plk_1 | 504 | 510 | PF00069 | 0.685 |
MOD_Plk_2-3 | 457 | 463 | PF00069 | 0.632 |
MOD_Plk_4 | 20 | 26 | PF00069 | 0.860 |
MOD_Plk_4 | 412 | 418 | PF00069 | 0.574 |
MOD_Plk_4 | 457 | 463 | PF00069 | 0.632 |
MOD_Plk_4 | 477 | 483 | PF00069 | 0.400 |
MOD_ProDKin_1 | 239 | 245 | PF00069 | 0.823 |
MOD_ProDKin_1 | 316 | 322 | PF00069 | 0.807 |
MOD_ProDKin_1 | 554 | 560 | PF00069 | 0.848 |
MOD_SUMO_for_1 | 411 | 414 | PF00179 | 0.632 |
MOD_SUMO_rev_2 | 382 | 392 | PF00179 | 0.680 |
TRG_DiLeu_BaEn_1 | 505 | 510 | PF01217 | 0.694 |
TRG_ENDOCYTIC_2 | 383 | 386 | PF00928 | 0.702 |
TRG_ENDOCYTIC_2 | 479 | 482 | PF00928 | 0.632 |
TRG_ER_diArg_1 | 126 | 129 | PF00400 | 0.771 |
TRG_NLS_MonoCore_2 | 395 | 400 | PF00514 | 0.632 |
TRG_NLS_MonoExtC_3 | 395 | 400 | PF00514 | 0.632 |
TRG_Pf-PMV_PEXEL_1 | 124 | 128 | PF00026 | 0.764 |
TRG_Pf-PMV_PEXEL_1 | 335 | 339 | PF00026 | 0.729 |
TRG_Pf-PMV_PEXEL_1 | 434 | 438 | PF00026 | 0.432 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A3S7WRX6 | Leishmania donovani | 95% | 100% |
E9AGC2 | Leishmania infantum | 95% | 100% |
E9ANW2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 98% |